These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 37067420

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
    Ouchi Y, Mukai T, Koide K, Yamaguchi T, Park JH, Kim H, Yokoyama K, Tamaru A, Gordon SV, Nakajima C, Suzuki Y.
    Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929
    [Abstract] [Full Text] [Related]

  • 24. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
    Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A, Alexander C, Kaiga A, Stratton CW, Warkentin J, Tang YW, Sterling TR.
    J Clin Microbiol; 2012 Apr; 50(4):1390-6. PubMed ID: 22189117
    [Abstract] [Full Text] [Related]

  • 25. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW, Mbuchi M, Eyase FL, Bulimo WD, Kyanya CK, Oundo V, Muriithi SW, Andagalu B, Mbinda WM, Soge OO, McClelland RS, Sang W, Mancuso JD.
    BMC Microbiol; 2019 Apr 08; 19(1):76. PubMed ID: 30961546
    [Abstract] [Full Text] [Related]

  • 26. Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
    Qiao M, Ren W, Guo H, Huo F, Shang Y, Wang Y, Gao M, Pang Y.
    Int J Infect Dis; 2021 May 08; 106():295-299. PubMed ID: 33864922
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
    Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE.
    PLoS One; 2012 May 08; 7(6):e39754. PubMed ID: 22761889
    [Abstract] [Full Text] [Related]

  • 32. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
    Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A.
    J Antimicrob Chemother; 2012 Apr 08; 67(4):819-31. PubMed ID: 22279180
    [Abstract] [Full Text] [Related]

  • 33. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
    Pitaksajjakul P, Wongwit W, Punprasit W, Eampokalap B, Peacock S, Ramasoota P.
    Southeast Asian J Trop Med Public Health; 2005 Apr 08; 36 Suppl 4():228-37. PubMed ID: 16438215
    [Abstract] [Full Text] [Related]

  • 34. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.
    Sutera V, Hoarau G, Renesto P, Caspar Y, Maurin M.
    Int J Antimicrob Agents; 2017 Sep 08; 50(3):377-383. PubMed ID: 28689870
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
    Nakase K, Sakuma Y, Nakaminami H, Noguchi N.
    Anaerobe; 2016 Dec 08; 42():166-171. PubMed ID: 27793740
    [Abstract] [Full Text] [Related]

  • 38. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
    Mayer C, Takiff H.
    Microbiol Spectr; 2014 Aug 08; 2(4):MGM2-0009-2013. PubMed ID: 26104201
    [Abstract] [Full Text] [Related]

  • 39. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K, Wołkowicz T, Zacharczuk K, Rzeczkowska M, Chróst A, Bareja E, Olak M, Gierczyński R.
    Int J Antimicrob Agents; 2015 Mar 08; 45(3):238-43. PubMed ID: 25468717
    [Abstract] [Full Text] [Related]

  • 40. Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.
    Singhal R, Reynolds PR, Marola JL, Epperson LE, Arora J, Sarin R, Myneedu VP, Strong M, Salfinger M.
    J Clin Microbiol; 2016 Sep 08; 54(9):2298-305. PubMed ID: 27335153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.